PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmo... PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.6 | 2.08 | 125 | 130 | 121.8 | 360505 | 125.33451926 | DE |
| 4 | 0.6 | 0.472440944882 | 127 | 142 | 121.8 | 478155 | 132.14703919 | DE |
| 12 | 9.6 | 8.13559322034 | 118 | 142 | 107.4 | 667325 | 124.93791906 | DE |
| 26 | 7.2 | 5.98006644518 | 120.4 | 142 | 107.4 | 541600 | 126.42648882 | DE |
| 52 | -12 | -8.59598853868 | 139.6 | 148 | 104.8 | 566883 | 126.34954238 | DE |
| 156 | -100.4 | -44.0350877193 | 228 | 240 | 100.4 | 502694 | 152.38489468 | DE |
| 260 | -269.4 | -67.8589420655 | 397 | 397 | 100.4 | 422224 | 178.51672038 | DE |
JakBqk
5分前
barnyarddog
5分前
ExtremelyBullishZig
7分前
endlich0
9分前
price_and_volume
9分前
silverman8
9分前
price_and_volume
13分前
barnyarddog
14分前
peafunke
14分前
wshaw14
16分前
peafunke
18分前
ScottishTexan
20分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。